Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

42

Revenue 2017

Cialis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Cialis was produced by Lilly.

Sanofi narrows focus, shedding diabetes and cardiovascular research

Sanofi narrows focus, shedding diabetes and cardiovascular research

We believe the new standalone structure, coupled with plans to accelerate the over-the-counter switches for Cialis and Tamiflu, will position the business well to accomplish this ambition,” he added.

Pricing pressures peg back Lilly’s growth products

Pricing pressures peg back Lilly’s growth products Lilly was still able to post modest sales growth of 3% to $5.1bn, despite the ongoing impact of generic competition to its big-selling erectile dysfunction drug Cialis (tadalafil), but ... Lilly has other new medicines rolling out to help it manage the

Trulicity’s ascent lifts Lilly

Trulicity’s ascent lifts Lilly These new medicines will be needed to offset continued decline in its older blockbuster medicines, Cialis and Forteo and Humulin, which all earned over $1bn in 2018, but will start to

Brand teams: why are some smarter than others?

Brand teams: why are some smarter than others? They defeat powerful incumbents, like Cialis did with Viagra, or they overcome health-system conservatism, as Abbot is doing with its FreeStyle Libre device.

FDA approves Sanofi's follow-on version of Lilly’s Humalog

FDA approves Sanofi's follow-on version of Lilly’s Humalog Humalog is just one of Lilly’s big brands facing competition, along with erectile dysfunction therapy Cialis (tadalafil) and antiplatelet drug Effient (prasugrel), and the company recently announced sweeping job cuts

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics